Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Umbrella Phase 1b, Open-label, Multi-Cohort Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Novel Antiretrovirals in Participants With HIV-1; Substudy-04: GS-1219

NCT07115368 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT07115368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07115368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Umbrella Phase 1b, Open-label, Multi-Cohort Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Novel Antiretrovirals in Participants With HIV-1; Substudy-04: GS-1219
Lead sponsor
Gilead Sciences
Phase
Phase 1
Overall status
Terminated
Start date
August 11, 2025
Completion date
October 2, 2025
Enrollment
4 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection